Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

The Bull and Bear Case for Rivian (RIVN) Stock

Investors in Rivian and RIVN stock have plenty of risks to consider, but is this emerging electric vehicle player worth considering now?

Should You Buy Palantir Stock Before Dec. 31?

Palantir has been a clear winner from the surge in interest around AI stock. But can this company continue its impressive rally into 2024?

MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer

Moderna is in focus after reporting positive results for its cancer treatment today, with MRNA stock surging more than 9%.

Year-End IRA Contributions? 3 Stocks to Enhance Your Portfolio.

The list of companies is massive for those looking for IRA contribution stocks. Here are three top options to consider.

Bonk Price Predictions: How High Can a Coinbase Listing Take the BONK Crypto?

The Bonk crypto just scored a listing on Coinbase. What does that mean for the future of BONK price predictions? Let's take a look.